Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.
Who will be affected?
Readers: No access to all 28 journals. We recommend accessing our articles via PubMed Central
Authors: No access to the submission form or your user account.
Reviewers: No access to your user account. Please download manuscripts you are reviewing for offline reading before Wednesday, July 01, 2020 at 7:00 PM.
Editors: No access to your user account to assign reviewers or make decisions.
Copyeditors: No access to user account. Please download manuscripts you are copyediting before Wednesday, July 01, 2020 at 7:00 PM.
The continuing value of CD4 cell count monitoring to differential HIV care and surveillance
Brian Rice;
Andrew Boulle;
Sandra Schwarcz;
Amir Shroufi;
George Rutherford;
James Hargreaves
ABSTRACT
The move towards the universal provision of antiretroviral therapy, and the expansion of HIV viral load monitoring, calls into question the ongoing value of CD4 cell count testing and monitoring. We highlight the role CD4 monitoring continues to have in guiding clinical decisions and in measuring and evaluating the epidemiology of HIV. To end the HIV/AIDS epidemic we require strategic information, which includes CD4 cell counts, to make informed clinical decisions and to effectively monitor key surveillance indicators.
Citation
Please cite as:
Rice B, Boulle A, Schwarcz S, Shroufi A, Rutherford G, Hargreaves J
The Continuing Value of CD4 Cell Count Monitoring for Differential HIV Care and Surveillance